Latest Breaking News On - Potential one time treatment - Page 1 : comparemela.com

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual.

Kamy poolerGreg davisAmerican society of gene cell therapyDevelopment of bloodHead of research at sangamoDevelopment of modular integrases mintsHead of technology at sangamoSangamo therapeutics incFormulation developmentExchange commissionSangamo therapeuticsAmerican societyCell therapyModular integrasesDravet syndromeMeeting presentations